pyridostigmine bromide has been researched along with Becker Muscular Dystrophy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amancio, GCS; Barcellos, NMS; Cazorla, O; Grabe-Guimarães, A; Haikel, D; Lacampagne, A; Matecki, S; Moreau, J | 1 |
| Forst, J; Goerlitz, P; Muenster, T; Schmitt, HJ | 1 |
2 other study(ies) available for pyridostigmine bromide and Becker Muscular Dystrophy
| Article | Year |
|---|---|
Effect of pyridostigmine on in vivo and in vitro respiratory muscle of mdx mice.
Topics: Age Factors; Animals; Cholinesterase Inhibitors; Disease Models, Animal; Drug Delivery Systems; In Vitro Techniques; Liposomes; Male; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Muscle Contraction; Muscular Dystrophy, Duchenne; Plethysmography; Pyridostigmine Bromide; Respiration Disorders; Respiratory Muscles; Respiratory Rate; Spectrophotometry, Ultraviolet; Tidal Volume | 2017 |
Reversal of rocuronium-induced neuromuscular blockade by pyridostigmine in patients with Duchenne muscular dystrophy.
Topics: Adolescent; Adult; Androstanols; Child; Cholinesterase Inhibitors; Electromyography; Humans; Male; Muscular Dystrophy, Duchenne; Neuromuscular Blockade; Neuromuscular Nondepolarizing Agents; Pyridostigmine Bromide; Rocuronium; Time Factors; Transcutaneous Electric Nerve Stimulation | 2008 |